Publicaciones en las que colabora con MANUEL RUBEN QUEIRO SILVA (19)

2024

  1. Influence of the HLA-Cw6 Allele and IFIH1/MDA5 Gene Variants on the Cardiometabolic Risk Profile of Patients with Psoriatic Disease

    Journal of Clinical Medicine, Vol. 13, Núm. 3

2023

  1. The IFIH1/MDA5 rs1990760 Gene Variant (946Thr) Differentiates Early- vs. Late-Onset Skin Disease and Increases the Risk of Arthritis in a Spanish Cohort of Psoriasis

    International Journal of Molecular Sciences, Vol. 24, Núm. 19

2021

  1. Genetic variants of the NF-κB pathway: Unraveling the genetic architecture of psoriatic disease

    International Journal of Molecular Sciences, Vol. 22, Núm. 23

2019

  1. NFKBIZ and CW6 in Adalimumab Response Among Psoriasis Patients: Genetic Association and Alternative Transcript Analysis

    Molecular Diagnosis and Therapy, Vol. 23, Núm. 5, pp. 627-633

  2. Gene Variant in the NF- κ B Pathway Inhibitor NFKBIA Distinguishes Patients with Psoriatic Arthritis within the Spectrum of Psoriatic Disease

    BioMed Research International, Vol. 2019

2017

  1. NFKBIZ in Psoriasis: Assessing the association with gene polymorphisms and report of a new transcript variant

    Human Immunology, Vol. 78, Núm. 5-6, pp. 435-440

2016

  1. A Single Nucleotide Polymorphism in the Il17ra Promoter Is Associated with Functional Severity of Ankylosing Spondylitis

    PLoS ONE, Vol. 11, Núm. 7

  2. Common and rare CARD14 gene variants affect the antitumour necrosis factor response among patients with psoriasis

    British Journal of Dermatology, Vol. 175, Núm. 1, pp. 134-141

2015

  1. Association between single nucleotide polymorphisms IL17RA rs4819554 and IL17E rs79877597 and Psoriasis in a Spanish cohort

    Journal of Dermatological Science, Vol. 80, Núm. 2, pp. 111-115

  2. CDKAL1 gene variants affect the anti-TNF response among Psoriasis patients

    International Immunopharmacology, Vol. 29, Núm. 2, pp. 947-949

  3. Cardiovascular risk factors influence response to biological therapies in psoriasis

    Journal of the American Academy of Dermatology, Vol. 73, Núm. 2, pp. 327-329

  4. The Cw6 and late-cornified envelope genotype plays a significant role in anti-tumor necrosis factor response among psoriatic patients

    Pharmacogenetics and Genomics, Vol. 25, Núm. 6, pp. 313-316

  5. The TNFRSF1B rs1061622 polymorphism (p.M196R) is associated with biological drug outcome in Psoriasis patients

    Archives of Dermatological Research, Vol. 307, Núm. 5, pp. 405-412

2014

  1. Effect of the FTO rs9930506 polymorphism on obesity and the main clinical outcomes in patients with psoriasis

    British Journal of Dermatology

  2. Genetic variation at IL12B, IL23R and IL23A is associated with psoriasis severity, psoriatic arthritis and type 2 diabetes mellitus

    Journal of Dermatological Science, Vol. 75, Núm. 3, pp. 167-172

2013

  1. Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: A systematic review and meta-analysis

    British Journal of Dermatology, Vol. 169, Núm. 4, pp. 783-793

  2. SNP rs11652075 in the CARD14 gene as a risk factor for psoriasis (PSORS2) in a Spanish Cohort

    DNA and Cell Biology, Vol. 32, Núm. 10, pp. 601-604

2012

  1. Resequencing of the IL12B gene in psoriasis patients with the rs6887695/rs3212227 risk genotypes

    Cytokine, Vol. 60, Núm. 1, pp. 27-29

2010

  1. Mutation analysis of the LCE3B/LCE3C genes in Psoriasis

    BMC Medical Genetics, Vol. 11, Núm. 1